Ida Johansson (Former)
1 – 15 of 15
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Transcriptional profiling of breast cancer metastases identifies liver metastasis-selective genes associated with adverse outcome in luminal A primary breast cancer.
(
- Contribution to journal › Article
- 2015
-
Mark
Global transcriptional changes following statin treatment in breast cancer.
(
- Contribution to journal › Article
-
Mark
Genome methylation patterns in male breast cancer - Identification of an epitype with hypermethylation of polycomb target genes.
(
- Contribution to journal › Article
- 2014
-
Mark
Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes.
(
- Contribution to journal › Article
-
Mark
Nuclear HIF1A expression is strongly prognostic in sporadic but not familial male breast cancer.
(
- Contribution to journal › Article
-
Mark
Molecular profiling of male breast cancer - Lost in translation?
(
- Contribution to journal › Scientific review
-
Mark
32p * biomarkers and molecular subtypes in primary breast tumors and metastases: associations with liver metastases and outcome.
(
- Contribution to journal › Article
- 2013
-
Mark
The Landscape of Candidate Driver Genes Differs between Male and Female Breast Cancer.
(
- Contribution to journal › Article
-
Mark
Molecular Characterization of Male Breast Cancer
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact
(
- Contribution to journal › Article
-
Mark
High proliferation is associated with inferior Outcome in male breast cancer patients
(
- Contribution to journal › Article
- 2012
-
Mark
Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker
(
- Contribution to journal › Article
-
Mark
Increased gene copy number of KIT and VEGFR2 at 4q12 in primary breast cancer is related to an aggressive phenotype and impaired prognosis.
(
- Contribution to journal › Article
-
Mark
Co-targeting of the PI3K pathway improves the response of BRCA1 deficient breast cancer cells to PARP1 inhibition.
(
- Contribution to journal › Article
- 2011
-
Mark
High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer
(
- Contribution to journal › Article